当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Wataru Shiraishi*
Creutzfeldt-Jakob Disease (CJD) is a rare, progressive, and fatal neurodegenerative disorder caused by
misfolded prion proteins. CJD shows characteristic clinical manifestations of rapidly progressive dementia,
myoclonus, pyramidal or extrapyramidal dysfunction, and akinetic mutism. Laboratory tests, such as Periodic Sharp
Wave Complexes (PSWCs) on electroencephalography, elevated Cerebrospinal Fluid (CSF) 14-3-3 protein levels or
total tau levels, and magnetic resonance imaging findings of cortical (cortical ribboning) or bilateral thalamic (pulvinar
sign) lesions, are useful diagnostic tools. However, an accurate diagnosis is sometimes challenging. We recently
reported a patient with posterior reversible encephalopathy syndrome with seizures and consciousness disturbance
with elevated CSF 14-3-3 protein levels, PSWCs, and the pulvinar sign, suggesting CJD. From our experience of
this case, we learned that test results characteristic of CJD can be obtained with other diseases, i.e., CJD mimics. In
this review, we will discuss CJD test results and their interpretation.